nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Case of Acute Promyelocytic Leukemia Without RARα Rearrangement and Apparently Normal Cytogenetics
|
Vaklavas, Christos |
|
2011 |
11 |
6 |
p. 521-524 4 p. |
artikel |
2 |
A Prospective Phase II Study of RICE Re-Induction, Then High-Dose Fludarabine and Busulfan, Followed by Autologous or Allogeneic Blood Stem Cell Transplantation for Indolent B-Cell Lymphoma. ClinicalTrials.gov ID: NCT00144092
|
Stewart, Douglas A. |
|
2011 |
11 |
6 |
p. 475-482 8 p. |
artikel |
3 |
Clinical Outcomes of Patients With Plasma Cell Leukemia in the Era of Novel Therapies and Hematopoietic Stem Cell Transplantation Strategies: A Single-Institution Experience
|
Lebovic, Daniel |
|
2011 |
11 |
6 |
p. 507-511 5 p. |
artikel |
4 |
Combination of Lenalidomide and Rituximab in Elderly Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Phase 2 Trial
|
Zinzani, Pier Luigi |
|
2011 |
11 |
6 |
p. 462-466 5 p. |
artikel |
5 |
Cutaneous and Systemic Plasmacytosis vs. Cutaneous Plasmacytic Castleman Disease: Review and Speculations About Pathogenesis
|
Haque, Maryam |
|
2011 |
11 |
6 |
p. 453-461 9 p. |
artikel |
6 |
EBV-Positive Diffuse Large B-Cell Lymphoma in Young Immunocompetent Individuals
|
Beltran, Brady E. |
|
2011 |
11 |
6 |
p. 512-516 5 p. |
artikel |
7 |
Editorial Board/Masthead
|
|
|
2011 |
11 |
6 |
p. A8- 1 p. |
artikel |
8 |
Interstitial Pneumonia After Autologous Hematopoietic Stem Cell Transplantation in B-Cell Non-Hodgkin Lymphoma
|
Kato, Harumi |
|
2011 |
11 |
6 |
p. 483-489 7 p. |
artikel |
9 |
Multiple Myeloma Associated IgA Pemphigus: Treatment With Bortezomib- and Lenalidomide-Based Regimen
|
Szturz, Petr |
|
2011 |
11 |
6 |
p. 517-520 4 p. |
artikel |
10 |
Racial Differences in the Presentation and Outcomes of Chronic Lymphocytic Leukemia and Variants in the United States
|
Shenoy, Pareen J. |
|
2011 |
11 |
6 |
p. 498-506 9 p. |
artikel |
11 |
Ribosomal Protein Metallopanstimulin-1 Impairs Multiple Myeloma CAG Cells Growth and Inhibits Fibroblast Growth Factor Receptor 3
|
Dai, Yuemeng |
|
2011 |
11 |
6 |
p. 490-497 8 p. |
artikel |
12 |
Safety and Efficacy of Combination Therapy with Fludarabine, Mitoxantrone, and Rituximab Followed by Yttrium-90 Ibritumomab Tiuxetan and Maintenance Rituximab as Front-Line Therapy for Patients With Follicular or Marginal Zone Lymphoma
|
Karmali, Reem |
|
2011 |
11 |
6 |
p. 467-474 8 p. |
artikel |
13 |
Table of Contents
|
|
|
2011 |
11 |
6 |
p. A11-A12 nvt p. |
artikel |